SeekingAlpha · Aug 4, 2026
BMEZ: Ride On Multiple Tailwinds Amid Sector Rotation
Explore BlackRock Health Sciences Trust II (BMEZ): a diversified biotech/pharma CEF at a ~10% NAV discount, with covered calls and 2026 tailwindsâread now.
NYSE · BMEZ
BlackRock Health Sciences Trust II
Financial Services · Asset Management
$16.24
Down-$0.08 (-0.50%)
Updated Aug 15, 2026, 12:51 AM
SID Score
6.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.54B
- P/E ratio
- 8.62
- Dividend yield
- 11.93%
- 52-week range
- $13.70 – $16.25
- Volume
- 116.04K
- Avg. volume
- 282.63K
Price performance
BMEZ price history
1M range · 20 trading sessions · Daily adjusted prices
BMEZ closed at $16.24 after 20 trading sessions, up 6.35% for the selected period.
- Last close
- $16.24
- Period change
- +6.35%
- Period low
- $15.14
- Period high
- $16.24
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 13, 2026 | $16.20 | $16.25 | $16.13 | $16.24 | 116.04K |
| Aug 12, 2026 | $16.11 | $16.2478 | $16.1001 | $16.19 | 109.86K |
| Aug 11, 2026 | $16.18 | $16.20 | $16.10 | $16.15 | 128.74K |
| Aug 10, 2026 | $15.98 | $16.175 | $15.97 | $16.12 | 98.49K |
| Aug 7, 2026 | $15.68 | $16.00 | $15.651 | $15.97 | 147.99K |
| Aug 6, 2026 | $15.69 | $15.7999 | $15.63 | $15.71 | 114.45K |
| Aug 5, 2026 | $15.60 | $15.6999 | $15.60 | $15.62 | 126.29K |
| Aug 4, 2026 | $15.66 | $15.66 | $15.42 | $15.55 | 112.5K |
| Aug 3, 2026 | $15.51 | $15.685 | $15.375 | $15.58 | 160.31K |
| Jul 31, 2026 | $15.63 | $15.69 | $15.35 | $15.48 | 151.8K |
| Jul 30, 2026 | $15.45 | $15.635 | $15.42 | $15.60 | 88.84K |
| Jul 29, 2026 | $15.50 | $15.59 | $15.40 | $15.46 | 137.8K |
| Jul 28, 2026 | $15.39 | $15.55 | $15.36 | $15.49 | 115.72K |
| Jul 27, 2026 | $15.33 | $15.47 | $15.301 | $15.36 | 63.36K |
| Jul 24, 2026 | $15.21 | $15.39 | $15.21 | $15.31 | 82.87K |
| Jul 23, 2026 | $14.99 | $15.2899 | $14.99 | $15.18 | 71.76K |
| Jul 22, 2026 | $15.29 | $15.39 | $15.105 | $15.14 | 89.97K |
| Jul 21, 2026 | $15.14 | $15.33 | $15.10 | $15.30 | 100.57K |
| Jul 20, 2026 | $15.24 | $15.29 | $15.10 | $15.14 | 131.39K |
| Jul 17, 2026 | $15.30 | $15.35 | $15.20 | $15.27 | 252.13K |
Latest BMEZ news
The latest Smart Investors Daily articles mentioning BMEZ.
Stock researchCompany · Overview
BMEZ research
Overview
Company profile and research snapshot.
Company profile
BlackRock Health Sciences Trust II is a closed-ended management investment company. The investment objective is to provide total return through a combination of current income and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of energy and natural resources companies and equity derivatives with exposure to the energy and natural resources industry.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
SeekingAlpha · Jun 24, 2026
BlackRock Health Sciences Term Trust Q1 2026 Commentary
Over the quarter, the BlackRock Health Sciences Term Trust increased its exposure to pharmaceuticals and biotechnology firms.
SeekingAlpha · Jan 6, 2026
BlackRock Health Sciences Term Trust Q3 2025 Commentary
BlackRock Health Sciences Term Trust returned +4.7% on market price and +8.2% on net asset value during Q3 2025. Read more here.
SeekingAlpha · Jan 3, 2026
BMEZ: Deep Discount Once Again Makes It An Interesting Play
BMEZ trades at a 12% discount after ending options writing and cutting its payoutâlearn what this means for biotech-heavy returns and income.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
